{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T18:40:54Z","timestamp":1682793654078},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf00335305","type":"journal-article","created":{"date-parts":[[2004,10,26]],"date-time":"2004-10-26T12:34:09Z","timestamp":1098794049000},"page":"297-300","source":"Crossref","is-referenced-by-count":2,"title":["Totally implanted catheters to reduce catheter-related infections in patients receiving interleukin-2: a 2-year experience"],"prefix":"10.1007","volume":"3","author":[{"given":"B.","family":"Escudier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Lethiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nitenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Angevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Andremont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Cosset-Delaigue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1200\/JCO.1990.8.1.161","volume":"8","author":"SN Bock","year":"1990","unstructured":"Bock SN, Lee RE, Fisher B, Rubin JT, et al (1990) A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol 8:161?169","journal-title":"J Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF00257682","volume":"13","author":"E Dominguez-de Villota","year":"1987","unstructured":"Dominguez-de Villota E, Algora-Weber A, Millan I, et al (1987) Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients. A clinically uncertain judgement. Intensive Care Med 13:390?394","journal-title":"Intensive Care Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0959-8049(05)80354-5","volume":"5","author":"B Escudier","year":"1993","unstructured":"Escudier B, Farace F, Angevin E, et al (1993) Combination of interleukin-2 and gamma interferon in metastatic renal cell carcinoma. Eur J Cancer 5:724?728","journal-title":"Eur J Cancer"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0959-8049(94)90460-X","volume":"30","author":"B Escudier","year":"1994","unstructured":"Escudier B, Farace F, Angevin E, et al (1994) Immunotherapy with IL-2 and lymphokine activated natural killer (LANAK) cells: improvement of clinical responses in MRCC patients previously treated with IL-2. Eur J Cancer 30:1078?1083","journal-title":"Eur J Cancer"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/jnci\/81.15.1190","volume":"81","author":"LC Hartmann","year":"1989","unstructured":"Hartmann LC, Urba WJ, Steis RG, et al (1989) Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patients, J Natl Cancer Inst 81:1190?1193","journal-title":"J Natl Cancer Inst"},{"key":"CR6","first-page":"546","volume":"9","author":"T Hercend","year":"1990","unstructured":"Hercend T, Farace F, Baume D, et al (1990) Immunotherapy with lymphokine activated natural killer (LANAK) cells and rIL-2: a feasability trial in metastatic renal cell carcinoma. J Biol Response Mod 9:546?555","journal-title":"J Biol Response Mod"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.4049\/jimmunol.144.9.3630","volume":"144","author":"D Jablons","year":"1990","unstructured":"Jablons D, Bolton E, Mertins S (1990) IL-2-based immunotherapy alters circulating neutrophil Fc receptors expression and chemotaxis. J Immunol 144:3630?3636","journal-title":"J Immunol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-119-4-199308150-00010","volume":"119","author":"JA Jernigan","year":"1993","unstructured":"Jernigan JA, Farr BM (1993) Short course therapy of catheter-related Staphylococcus aureus bacteremia: a metaanalysis. Ann Intern Med 119:304?311","journal-title":"Ann Intern Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1056\/NEJM199004053221404","volume":"322","author":"MS Klempner","year":"1990","unstructured":"Klempner MS, Noring R, Mier JW, Atkins MB (1990) An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med 322:959?965","journal-title":"N Engl J Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/JCM.27.10.2305-2308.1989","volume":"27","author":"S Maoleekoonpairoj","year":"1989","unstructured":"Maoleekoonpairoj S, Mittelman A, Savona S, et al (1989) Lack of protection against bacterial infections in patients with advanced cancer treated by biologic response modifiers. J Clin Microbiol 27:2305?2308","journal-title":"J Clin Microbiol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-110-1-9","volume":"110","author":"MA Martin","year":"1989","unstructured":"Martin MA, Pfaller MA, Wenzel RP (1989) Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 110:9?16","journal-title":"Ann Intern Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-108-1-36","volume":"108","author":"PM Murphy","year":"1988","unstructured":"Murphy PM, Lane HC, Gallin JI, Fauci AS (1988) Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon ?. Ann Intern Med 108:36?41","journal-title":"Ann Intern Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.4049\/jimmunol.139.8.2737","volume":"139","author":"RJ Natuk","year":"1987","unstructured":"Natuk RJ, Welsh RM (1987) Chemotactic effect of human recombinant interleukin-2 on mouse activated large granular lymphocytes. J Immunol 139:2737?2743","journal-title":"J Immunol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/infdis\/164.6.1168","volume":"164","author":"RL Penn","year":"1991","unstructured":"Penn RL, Nguyen VQ, Specian RD, Stevens P, Berg RD (1991) Interleukin-2 enhances the translocation of Escherichia coli from the intestines to other organs. J Infect Dis 164:1168?1172","journal-title":"J Infect Dis"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/1097-0142(19910315)67:6<1570::AID-CNCR2820670619>3.0.CO;2-V","volume":"67","author":"JM Richards","year":"1991","unstructured":"Richards JM, Gilewski TA, Vogelzang NJ (1991) Association of interleukin-2 therapy with staphylococcal bacteremia. Cancer 67:1570?1575","journal-title":"Cancer"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","volume":"316","author":"SA Rosenberg","year":"1987","unstructured":"Rosenberg SA, Lotze MT, Muul LM, et al (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 316:889?897","journal-title":"N Engl J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7326\/0003-4819-112-2-102","volume":"112","author":"DR Snydman","year":"1990","unstructured":"Snydman DR, Sullivan B, Gall M, et al (1990) Nosocomial sepsis associated with interleukin-2. Ann Intern Med 112:102?107","journal-title":"Ann Intern Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM198704093161502","volume":"316","author":"WH West","year":"1987","unstructured":"West WH, Tauer KW, Yannelli JR, et al (1987) Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316:898?905","journal-title":"N Engl J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00335305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00335305\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00335305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T18:09:35Z","timestamp":1682791775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00335305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF00335305"],"URL":"https:\/\/doi.org\/10.1007\/bf00335305","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}